Australians living with a type of Motor Neurone Disease will have access to a new, cheaper treatment to help slow the ...
Australians living with motor neurone disease (MND) will now have cheaper access to treatment through the Pharmaceutical ...
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing ...
23h
Sandra Bullock's wake-up call that changed everything during late partner Bryan Randall’s illness
Sandra Bullock reveals her sister's urgent warning forced her to confront the hidden toll of caregiving during partner Bryan ...
A disease-modifying drug aimed at a rare genetic subtype of motor neurone disease will be subsidised from next month, cutting ...
A German population-based registry study identifies survival patterns and predictors of longer survival in patients with ...
Today, PhenoNet, Inc., an advanced clinical-stage biotechnology company developing therapies for neurodegenerative diseases, announced the completion of recruitment and randomization on August 27, ...
Kim Borthwick signed up for Hoy's Tour de 4 ride and set about seeking support from cyclists to draw attention to her condition ...
Chris Johnson once made his name outrunning entire defenses, a first-round pick whose speed redefined the Tennessee Titans‘ backfield. Now he’s facing an opponent that doesn’t care how fast you are.
An emerging body of evidence has hinted that ALS survival may be influenced by exposure to toxins or pollutants in the environment. Specifically, a handful of prior studies have found that ALS ...
Enrollment is complete in a Phase 2b trial of PHENOGENE-1A for mild-to-moderate ALS. ALS is a progressive disorder in which motor neurons die, with nervous system inflammation thought to play a role.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results